Complete Response Letters

Orexo AB: Naloxone hydrochloride

What FDA's Complete Response Letters to the company say, in the letters' own words.

EphemerisX Research · Sep 30, 2026 · Sources: FDA, SEC

Complete Response Letter, Jul 15, 2024

(3) Based on the evaluation of the human factors (HF) validation study results, the user interface does not support the safe and effective use of the proposed product.

Complete Response Letter · Jul 15, 2024 · p. 3Open the letter at p. 3 ↗CRL_NDA217433_20240715:p1:s33

More Complete Response Letters

All companies in the CRL Tracker →

Updated Sep 30, 2026 · built from 283 companies in the EphemerisX knowledge graph. This page is regenerated as companies are added.